Dr. Gail Roboz on Medscape InDiscussion PodcastPosted: April 21, 2022
Dr. Gail Roboz recently joined the Medscape InDiscussion podcast, an audio series for healthcare professionals, for an in-depth dialogue regarding acute myeloid leukemia (AML) with colleagues from the MD Anderson Cancer Center in Houston, Texas.
In episode 1, they break down a subtype of AML called APL, or acute promyelocytic leukemia, including signs and symptoms, as well as the importance of getting the diagnosis right and the proper treatments.
Listen to the full episode here: https://www.medscape.com/viewarticle/964529
In episode 2, Dr. Roboz leads a discussion on why certain types of AML are classified differently and how treatment may change as a result. Here’s a preview of this podcast conversation in which they review the nuances and implications of these various molecular and genetic classifications in AML subtypes.
“We’re going to talk about good-risk acute myeloid leukemia (AML). I always struggle with this because AML is a bad disease. I worry sometimes as we’re talking to patients and we introduce the words “good” and “favorable”; I think patients sometimes think that means “don’t worry about it, we’ll live forever,” and I don’t think that’s quite right. But I want to launch the conversation by first defining what are we talking about. I think there’s confusion about assigning good or favorable risk just using cytogenetics, which is kind of the old way we used to do things, and then introducing molecular classifications”.
For the full episode, tune in: https://www.medscape.com/viewarticle/964531